Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12893-025-03351-4 http://scihub22266oqcxt.onion/10.1186/s12893-025-03351-4 C12696928!12696928 !41382295     free     free     free       BMC+Surg 2025 ; 25 (1 ): 588 Nephropedia Template TP {{tp|p=41382295 |t=2025. Hugo? robotically assisted surgery versus laparoscopic hysterectomy for benign gynecological diseases: a secondary data analysis of clinical records in Panama |pdf=|usr=}}{{41382295 }} gab.com Text Hugo robotically assisted surgery versus laparoscopic hysterectomy for benign gynecological diseases: a secondary data analysis of clinical records in Panama JO: BMC Surg http://www.kidney.de/pget.php?&tw=1&pmid=41382295 #FOAvip BACKGROUND: The study compared the characteristics of women undergoing Medtronic Hugo? robotically assisted surgery (RAS) versus laparoscopic surgery (LS) for benign hysterectomy at two hospitals in Panama. It also analyzed the types of surgery associated with shorter operating times. METHODS: We performed a retrospective secondary data analysis of clinical records, from 63 women who underwent RAS and 59 who had LS, between July 1, 2022, and June 29, 2023. We analyzed age, body mass index (BMI), indications for hysterectomy, surgical type, time, complications, and hospital stays using Chi-square tests, Wilcoxon rank sum tests, and multivariable linear regression. RESULTS: Compared to women who underwent LS, those in the RAS group were older and had lower BMI (p?=?0.018). Surgical time and blood loss were lower in the RAS group (76 min vs. 117 min and 30 ml vs. 200 ml, p?<?0.001). No complications occurred in either group. RAS was associated with a 22% reduction in surgical time after controlling for patients? age, BMI, preoperative diagnoses, uterine weight, and blood loss during surgery (p 0.005). CONCLUSION: Hugo? RAS showed a good safety profile and shorter operating time compared to laparoscopic hysterectomy, in contrast to previous research that indicated longer RAS durations. CLINICAL TRIAL NUMBER: Not applicable. Twit Text FOAVip Hugo robotically assisted surgery versus laparoscopic hysterectomy for benign gynecological diseases: a secondary data analysis of clinical records in Panama ????BMC Surg http://www.kidney.de/pget.php?&tw=1&pmid=41382295 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=41382295 #FOAvip English Wikipedia <ref>{{Cite pmid|41382295 }}</ref> Hugo? robotically assisted surgery versus laparoscopic hysterectomy for benign gynecological diseases: a secondary data analysis of clinical records in Panama #MMPMID41382295 Vargas Castillo CE ; Cáceres Yap MÁ ; Doubova SV ; Pérez Cuevas R ; Bonilla Cruz A BMC Surg 2025[Dec]; 25 (1 ): 588 PMID41382295 show ga BACKGROUND: The study compared the characteristics of women undergoing Medtronic Hugo? robotically assisted surgery (RAS) versus laparoscopic surgery (LS) for benign hysterectomy at two hospitals in Panama. It also analyzed the types of surgery associated with shorter operating times. METHODS: We performed a retrospective secondary data analysis of clinical records, from 63 women who underwent RAS and 59 who had LS, between July 1, 2022, and June 29, 2023. We analyzed age, body mass index (BMI), indications for hysterectomy, surgical type, time, complications, and hospital stays using Chi-square tests, Wilcoxon rank sum tests, and multivariable linear regression. RESULTS: Compared to women who underwent LS, those in the RAS group were older and had lower BMI (p?=?0.018). Surgical time and blood loss were lower in the RAS group (76 min vs. 117 min and 30 ml vs. 200 ml, p? ?Hugo? robotically assisted surgery versus laparoscopic hysterectomy fo(epmc).pdf DeepDyve Pubget Overpricing